Obesimed from Europe launches in the UK weight loss market and helps tackle the growing problem of childhood obesity.
Obesimed continues with great success in Europe and now launches in the UK into independent pharmacies and online with www.chemist.net . As the multi-million pound market in weight loss pills and meal replacement programmes grows, a large proportion of products have not been available and suitable for use by children, until now. The availability of Obesimed through pharmacy gives parents of overweight children the opportunity to discuss with the pharmacist, in confidence, any concerns of overeating, and helps overcome embarrassment regarding childhood obesity. This in turn will help parents manage the weight of children over 10 and help inform them of suitable ways of how to lose weight safely, and review the habits and influence within the family regarding lack of exercise, cooking and eating, which are common causes of obesity.
Purchase zithromax online
Obesimed medical weight loss device, is a clinically tried and tested product and is a class 11A medical device for the treatment of slight to extreme overweight, in adults and children of 10 years and over. Obesimed is Certified for the EU and BSi, the British Standard Institution, and is aimed at helping people with a BMI of 25+, which currently accounts for nearly half of the population of the UK and Ireland. For the thousands of people each week searching for an obesity treatment, then Obesimed offers a new choice for those who are susceptible to overeating.
Obesimed are presented in capsule form in sizes 45 and 135 capsules, so ideal for people considering weight loss tablets and a new way to lose weight safely. Obesimed ‘diet pills’ are taken with water one hour prior to mealtimes and prevents excessive eating as it is able to absorb large amounts of water and forms a natural substance that fills the stomach. This in turn makes the user feel full, and promotes a sensation of having a full stomach during and after the meal. Obesimed decreases the rate the food exits the stomach and forms a viscous gel matrix which is not metabolised, and passes out of the body unchanged. Extensive clinical trials continue to show a healthy rate of weight loss.
Chemist.net is a UK Royal Pharmaceutical Society Registered online pharmacy. As an established popular online chemist, chemist.net aims to supply discounted medicines to every internet user and provide fast delivery direct to the door. As a leading UK online pharmacy it can also supply monthly orders of leading nutritional supplements such as MorEPA Smart Fats, nutritional drinks such as Ensure, Fortisip, as well as mobility products, baby essentials, fragrances, and veterinary products.
Google was warned repeatedly about accepting ads from rogue pharmacies
According to a report published Saturday, Google was warned repeatedly by regulators about running ads from rogue online pharmacies.
It’s a problem that has plagued Google for years – how to deal with rogue online drug sellers. A report by the Wall Street Journal on Saturday says that, according to interviews and documents reviewed by the newspaper, the search engine giant was “warned repeatedly” by state regulators and industry watchdogs that a number of online pharmacies advertising on its network were doing so in violation of US laws.
Drugs from rogue sellers can be extremely dangerous – not only can the medication be bought without a prescription, but it might also be out of date. Even worse, the drug could, in some cases, be different to how it’s described on the packaging.
The WSJ report says that federal prosecutors are investigating whether the company knowingly took business from rogue pharmacies. If this is found to be the case, legal experts believe Google could face action over charges of aiding illegal online activity.
This may explain the news earlier this month that the company had set aside the sum of $500 million for a payment it believed it might have to make in relation to an investigation by the US Justice Department regarding its online advertising system. When that news surfaced, the specifics of the case were unknown, but it seems that the WSJ report could well be related to the issue.
According to the WSJ, Food and Drug Administration agents posing as representatives from illegal online pharmacies contacted Google, though whether any evidence was garnered in the sting is not clear.
Yahoo and Microsoft don’t believe they’re under any suspicion regarding the same issue, the report says.
Online pharmacy advertising is big business – research firm eMarketer estimates that it generates revenue of around $1 billion for the search engines, though it’s not certain how much of that is from rogue sellers. The WSJ reports a pretty shocking statistic though: “About 96% of Internet drug outlets appeared to be violating pharmacy laws or standards, according to a 2008 study by the National Association of Boards of Pharmacy, or NABP, a group representing state regulators in the U.S. and Canada.”
The fact that Google had been told about the issue on several occasions since 2003 puts it in something of a sticky position. In a letter written in 2003, for example, the NABP said it was “deeply concerned that these rogue Internet sites could be a front for criminals seeking to introduce adulterated medications, counterfeit drugs, or worse, to the American market.” Nothing was heard from Google in response, says the NABP.
The report says that in a 2008 letter from the National Center on Addiction and Substance Abuse at Columbia University (CASA) to the then Google chief executive Eric Schmidt, CASA said it had discovered “prominent displays of ads for rogue Internet pharmacies.” This letter came after Google had hired a company called PharmacyChecker to check the pharmacies advertising on its search engine site. PharmacyChecker says it never knowingly approved advertisements from rogue pharmacies.
In 2008, it seemed that Google was beginning to look at the matter more closely. On receiving a list of hundreds of illicit pharmacy advertisers, Google said it found the information “helpful” and that it was being used to “augment our filters for sites that violate our policies.”
The bad news is that LegitScript LLC, which monitors online drug sellers, found in 2009 that there were still serious problems regarding rogue pharmacies on Google’s search engine site. Interestingly, the report also said that “80% and 90% of Yahoo and Microsoft’s respective online drug advertisers were breaking the law.”
Google, Yahoo and Microsoft all dropped PharmacyChecker in 2010 and agreed to work with NABP’s list of verified pharmacies. According to the WSJ, Google is now meeting with federal prosecutors in a bid to resolve the issue before it reaches court.
Doctors and pharmacists encouraged to identify and work with caregivers to improve chronic disease management and medication adherence
A new study by researchers at Harvard University, Brigham and Women’s Hospital and CVS Caremark finds that 45 percent of people who provide care and support to relatives say they are more likely to be non-adherent to their personal medication regimen than to neglect providing medications to a loved one they are caring for. More than 65 million Americans describe themselves as caregivers and as the U.S. population ages that number is expected to grow.
In a study published online this week in the Journal of the American Pharmacists Association (JAPhA) the researchers said, “Approximately one-half of caregivers reported they are more likely to forgo their own medications than the medication needs of their caregivees, especially if cost was a problem, and that caring for their family members was more important than caring for themselves.” The researchers added, “Our findings indicate care-giving status may be an important characteristic for providers to identify and that caregivers may represent a fertile target for adherence interventions to improve chronic disease management and prevent chronic disease.”
The latest study is a product of CVS Caremark’s three-year collaboration with Harvard University and Brigham and Women’s Hospital to research pharmacy claims data to better understand patient behavior, and how the health care system can improve it, particularly around medication adherence. The JAPhA study was published as CVS Caremark is sponsoring a forum on adherence at the National Press Club in Washington, D.C., to discuss the research findings of its collaboration and to outline future research and program initiatives the company is pursuing to address the problem that is estimated to cost the U.S. health care system almost $300 billion annually.
For the JAPhA study, the research team conducted an online survey of 2,000 retail pharmacy customers of which 38 percent, or 762 respondents, described themselves as caregivers. Of that group:
45 percent said they somewhat or strongly agree that they are more likely to forget to take their own medications even though they provide family members with their medicine.
46 percent said caring for their family is more important than caring for themselves and 52 percent said they are more likely to sacrifice their own health to make sure they properly care for family members.
53 percent reported that managing both their personal health and caring for another is stressful and that they eat to cope with that stress.
When comparing caregivers with non-caregivers, caregivers said they are 10 percent more likely to forget taking their medicines, 11 percent are likely to stop taking their medications if they feel better and 13 percent said they are likely to forget filling their refills.
“We found there is a compelling relationship between care giving and medication adherence,” said William Shrank, MD, MSHS, of Brigham and Women’s Hospital and Harvard Medical School and lead author of the study. “Caregivers appear to be so focused on helping family members that they often forget to take care of themselves, behavior that can have severe consequences for their health and well-being. Health care professionals should identify and target this group to help them better manage their personal health while caring for family members.”
“These results highlight an important opportunity for our industry to work with a target population to increase adherence,” said Troyen A. Brennan, executive vice president and chief medical officer of CVS Caremark, and a co-author of the study. “Doctors need to identify caregivers so they can provide appropriate support. In addition, pharmacists are uniquely positioned to intervene and encourage caregivers to take their medicine because the caregiver is often the person who is picking up medications for both family members and themselves.”